Reference: Australian Government Department of Health Therapeutic Goods Administration https://www.tga.gov.au/resource/infographic-how-access-medicinal-cannabis; reported on 24 September 2020.
Reference: Australian Government Department of Health Therapeutic Goods Administration, https://www.tga.gov.au/medicinal-cannabis-guidance-documents reported on 29 April 2020.
Reference: Australian Government Department of Health Therapeutic Goods Administration https://www.tga.gov.au/sites/default/files/medicinal-cannabis-consumers-factsheet.pdf reported on 29 May 2018.
The Commonwealth Government controls all regulatory aspects of the cultivation of Cannabis for Medicinal purposes through one national scheme. Manufacture is a joint responsibility between the Commonwealth and the states and territories. Access to any Cannabis products manufactured under the scheme will also be a joint responsibility, with supply being controlled by provisions under the Therapeutic Goods Act 1989 working in tandem with state and territory drugs and poisons legislation. For more information on Australian federal legislation, go to https://www.odc.gov.au/qa
The Office of Medicinal Cannabis has been established within the Department of Health and Human Services and provides advice on access to Medicinal Cannabis in Victoria. Read more about the Victorian situation at https://www2.health.vic.gov.au/public-health/drugs-and-poisons/medicinal-cannabis
The NSW Government has established the Centre for Medicinal Cannabis Research and Innovation to further the understanding of cannabis and cannabis products for therapeutic purposes, and support evidence-based innovation. Read more about the NSW situation at http://medicinalcannabis.nsw.gov.au/
Queensland is making the use of approved Medicinal Cannabis products possible as a treatment for certain conditions when the patient has already tried the conventional treatments available for their condition or symptoms, and these have failed or cause intolerable side-effects. Read more about the QLD situation at www.qld.gov.au/health/conditions/all/medicinal-cannabis
Medical practitioners in South Australia can legally prescribe Medicinal Cannabis products with Commonwealth and relevant state approvals. Read more: https://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/conditions/medicines/medicinal+cannabis/frequently+asked+questions+on+medicinal+cannabis
Doctors can prescribe and pharmacists can dispense Medicinal Cannabis in Western Australia. Read more about the situation in Western Australia at https://ww2.health.wa.gov.au/Articles/A_E/Cannabis-based-products.
The Tasmanian Government has developed a Medicinal Cannabis controlled access scheme (CAS). The scheme will allow relevant medical specialists to be authorised to prescribe medical cannabis (unregistered cannabinoid products) in limited circumstances where conventional treatment has been unsuccessful. Read more about the situation in Tasmania https://www.dhhs.tas.gov.au/psbtas/publications/medical_cannabis/medical_cannabis_controlled_access_scheme
Cannabis products can be prescribed as Schedule 8 controlled medicines in the ACT for medicinal uses. Read more about the situation in ACT at https://health.act.gov.au/health-professionals/pharmaceutical-services/controlled-medicines/medicinal-cannabis.
A patient living in the Northern Territory must access medicines containing cannabinoids through a Northern Territory doctor who is authorised under the Special Access or Authorised Prescriber Schemes administered by the Therapeutic Goods Administration. Read more about the situation in the Northern Territory at https://health.nt.gov.au/__data/assets/pdf_file/0005/809636/Access-medicinal-cannabis-and-CBD-oil-in-NT-information-sheet.pdf.